Evolution of the Average Target: IRADIMED CORPORATION

Evolution of the Average Target - IRADIMED CORPORATION

Evolution of the Target Price: IRADIMED CORPORATION

Evolution of the Target Price - IRADIMED CORPORATION

Changes in Analyst Recommendations: IRADIMED CORPORATION

b278.A8QzYhrnpTp48NtPCQSq6OiW168tpQUvbA8opTapRxw.TKZSG0KD4EIXh5QeYTLtjaT_mZ1X8GF6KX9q60PfDXpbo1QRN4vpbTbB7w~52743e7f0a8e41d9f402cc29193c7297

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+36.72%
+8.26%
+12.88%
+7.24%
+16.02%
+9.31%
+2.6%
+4.17%
+5.33%
+3.74%
Average +10.63%
Weighted average by Cap. +8.59%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
86.31USD
Average target price
118.00USD
Spread / Average Target
+36.72%
High Price Target
120.00USD
Spread / Highest target
+39.03%
Low Price Target
116.00USD
Spread / Lowest Target
+34.40%

Analyst Consensus Detail

Analyst consensus - IRADIMED CORPORATION

Consensus revision (last 18 months)

Consensus revision (last 18 months) - IRADIMED CORPORATION
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
  1. Stock Market
  2. Stocks
  3. IRMD Stock
  4. Consensus IRADIMED CORPORATION